Does EVOLOCUMAB Cause Flushing? 208 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 208 reports of Flushing have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
208
Reports of Flushing with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Flushing From EVOLOCUMAB?
Of the 208 reports, 11 (5.3%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Flushing Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 208 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Flushing?
DIMETHYL (10,681)
TREPROSTINIL (3,166)
TECFIDERA (2,385)
AMBRISENTAN (1,741)
DALFAMPRIDINE (1,605)
DIROXIMEL (1,518)
INFLIXIMAB (1,488)
PACLITAXEL (1,397)
GLATIRAMER (1,291)
EPOPROSTENOL (1,256)
Which EVOLOCUMAB Alternatives Have Lower Flushing Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE